A Study of NN3201 for Advanced Cancer
Phase 1
67
about 2.9 years
18+
5 sites in MI, OH, OR +2
What this study is about
Researchers are testing a new drug called NN3201 in people with advanced or metastatic solid tumors that have c-Kit. The goal is to see if the drug is safe and well-tolerated. The trial will involve two phases: a dose escalation phase to determine the maximum tolerated dose, followed by an expansion phase to assess the drug's effectiveness.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take NN3201
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Incidence of Adverse Events:
Secondary: Pharmacokinetics (PK) of NN3201
Oncology, Gastroenterology